VSY Biotechnology Introduces Golden Ratio in Trifocal IOL Technology
VSY Biotechnology has introduced the concept of “Golden Ratio in IOL Technology” with its AcrivaUD Trinova Pro C Pupil Adaptive IOL. The technology is designed to provide patients with a high level of visual quality at near, far, and everywhere in between—even at daily challenging light conditions.
The AcrivaUD Trinova Pro C Pupil Adaptive is the first trifocal IOL that combines patented enhanced Sinusoidal Vision Technology (SVT) with Pupil Adaptive Design, according to VSY Biotechnology. The lens will be commercially available after its launch at the ESCRS 2021 in Amsterdam, October 8-11, 2021.
AcrivaUD Trinova Pro C Pupil Adaptive has completed the pre-launch phase with more than 200 successful implantations worldwide. The comparative clinical study is still ongoing at Internationale Innovative Ophthalmochirurgie GbR (IIO), Germany, a research institute associated with the Breyer, Kaymak and Klabe Eye Clinic located in Düsseldorf, Germany. In addition, the Institute of Experimental Ophthalmologie at the Saarland University, in close collaboration with IIO, performs the optical bench tests on the lenses. Clinical studies and optical bench tests are directed by a consortium of experts comprising Hakan Kaymak, Achim Langenbucher, Kai Neller and Hartmut Schwahn. The aim of the current study is to demonstrate comparable distance vision, superior near and intermediate vision at challenging light conditions.
The new lens uses patented Sinusoidal Vision Technology (SVT), which is designed to distribute effective and efficient light energy into the near and intermediate distances while maintaining distance visual acuity due to minimized light loss in the diffraction orders.
AcrivaUD Trinova Pro C Pupil Adaptive will be available by +1.8D intermediate and +3.6D near addition dioptric powers in the IOL plane.
"The IOL adapts to today’s lifestyles from viewing road signs comfortably and clearly while driving at night safety, to viewing mobile devices and computer screens, to reading a book comfortably even in dim light providing high quality distance vision in a range of different light conditions," according to VSY Biotechnology. "By increasing the visual quality of the patients to the highest level, it improves the quality of life and offers a "Golden Ratio" vision experience."